Abstract
Originating at December 2019 in China, SARS-CoV-2 has emerged as the deadliest pandemic in the history of mankind. Along with direct contact and droplet contaminations, possibility of infections through contaminated surfaces and fomites are being investigated. In this study, we aim to assess the prevalence of SARS-CoV-2 viral RNA by real time one-step reverse transcriptase PCR on banknotes being circulating in Bangladesh. We also assessed the persistence of the virus on banknotes spiked with SARS-CoV-2 positive diluted human nasopharyngeal samples. Among the 425 banknote samples collected from different entities, 7.29% (n= 31) were tested positive for targeted genes. Twenty four representative positive samples were assessed for N gene fragments by conventional PCR and sequenced. All the samples carry viral RNA belonged to GR clade, the predominant circulating clade in Bangladesh. In the test of stability, the N gene was detected for up to 72 h on banknotes spiked with nasopharyngeal samples and CT values increases significantly with time (p<0.05). ORF1b gene was observed to be less stable specially on old banknotes and usually went beyond detectable limit within 8 to 10 h. The stability of virus RNA was well fitted by Weibull model and concave curve for new banknotes and convex curve for old banknotes have been revealed. Handling of banknotes is unavoidable; hence these findings implicated that in order to limit SARS-CoV-2 transmission through banknotes proper hygiene practice are needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research has been conducted under the fund allocated from Jashore University of Science and Technology through University Grants Commission (UGC) of Bangladesh.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional ethical review board of Jashore University of Science and Technology, Jashore, Bangladesh
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
not available